Click to search or browse MIMS
Icatibant is a selective competitive antagonist at the bradykinin type 2 (B2) receptor. It is a synthetic decapeptide with a structure similar to bradykinin, but with five non-proteinogenic amino acids.
In hereditary angioedema, increased bradykinin concentrations are the key mediator in the development of the clinical symptoms.
Further information: Jerini
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.